Latest Insider Transactions at Hca Healthcare, Inc. (HCA)
This section provides a real-time view of insider transactions for Hca Healthcare, Inc. (HCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCA Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCA Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 30
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+3.8%
|
-
|
Jan 30
2023
|
Richard A Hammett Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-1.67%
|
$36,938
$253.3 P/Share
|
Jan 30
2023
|
Richard A Hammett Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
598
+6.4%
|
-
|
Jan 29
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-1.42%
|
$24,384
$254.77 P/Share
|
Jan 29
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+4.56%
|
-
|
Jan 29
2023
|
Richard A Hammett Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.99%
|
$41,910
$254.77 P/Share
|
Jan 29
2023
|
Richard A Hammett Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+6.73%
|
-
|
Jan 28
2023
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
SELL
Payment of exercise price or tax liability
|
Direct |
489
-16.03%
|
$124,206
$254.77 P/Share
|
Jan 28
2023
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,940
+38.88%
|
-
|
Jan 23
2023
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,966
-11.81%
|
$780,058
$263.81 P/Share
|
Jan 23
2023
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+19.29%
|
$486,000
$81.96 P/Share
|
Nov 11
2022
|
Charles J Hall Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,440
-4.46%
|
$2,114,560
$224.08 P/Share
|
Nov 11
2022
|
Charles J Hall Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+5.36%
|
$1,740,000
$145.24 P/Share
|
Nov 11
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
10,000
-24.51%
|
$2,240,000
$224.07 P/Share
|
Nov 02
2022
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
450
-0.54%
|
-
|
Oct 31
2022
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Bona fide gift
|
Direct |
450
-1.78%
|
-
|
Oct 28
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,946
-100.0%
|
$2,886,958
$223.18 P/Share
|
Oct 28
2022
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
9,838
-4.69%
|
$2,193,874
$223.5 P/Share
|
Oct 28
2022
|
Charles J Hall Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
23,064
-9.91%
|
$5,143,272
$223.66 P/Share
|
Oct 28
2022
|
Charles J Hall Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,147
+6.4%
|
$3,737,640
$120.11 P/Share
|
Oct 28
2022
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Open market or private sale
|
Direct |
8,332
-17.01%
|
$1,849,704
$222.58 P/Share
|
Oct 27
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
17,709
-30.26%
|
$3,842,853
$217.77 P/Share
|
Oct 27
2022
|
A Bruce Moore Jr Group President - Service Line |
BUY
Exercise of conversion of derivative security
|
Direct |
35,625
+37.84%
|
$1,318,125
$37.18 P/Share
|
Oct 26
2022
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
8,243
-14.4%
|
$1,788,731
$217.48 P/Share
|
Oct 26
2022
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Exercise of conversion of derivative security
|
Direct |
16,575
+22.46%
|
$613,275
$37.18 P/Share
|
Oct 25
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,554
-52.92%
|
$3,114,556
$214.4 P/Share
|
Oct 25
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+50.0%
|
$1,292,500
$47.97 P/Share
|
Oct 25
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Indirect |
3,600
-10.79%
|
-
|
Oct 24
2022
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
2,000
-4.53%
|
$412,000
$206.04 P/Share
|
Aug 10
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Bona fide gift
|
Indirect |
17,051
+33.82%
|
-
|
Aug 10
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Direct |
17,051
-100.0%
|
-
|
Aug 04
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Indirect |
5,000
-23.45%
|
-
|
Jul 25
2022
|
Patricia F Elcan > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
325
+0.36%
|
$64,350
$198.66 P/Share
|
May 13
2022
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Open market or private sale
|
Direct |
2,358
-17.15%
|
$514,044
$218.87 P/Share
|
May 10
2022
|
Bill B Rutherford CFO and EVP |
BUY
Bona fide gift
|
Indirect |
18,640
+50.0%
|
-
|
May 10
2022
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Indirect |
18,640
-100.0%
|
-
|
May 03
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
500
-4.21%
|
$107,500
$215.38 P/Share
|
May 02
2022
|
Thomas F Frist Jr > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
89,100
+2.73%
|
$18,889,200
$212.48 P/Share
|
Apr 29
2022
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
BUY
Open market or private purchase
|
Direct |
1,110
+50.0%
|
$241,980
$218.56 P/Share
|
Apr 28
2022
|
Andrea B Smith Director |
BUY
Open market or private purchase
|
Direct |
1,160
+34.13%
|
$247,080
$213.63 P/Share
|
Apr 25
2022
|
Meg Crofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+15.13%
|
-
|
Apr 25
2022
|
Robert J Dennis Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+3.69%
|
-
|
Apr 25
2022
|
Thomas F Frist Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,899
+14.93%
|
-
|
Apr 25
2022
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+4.42%
|
-
|
Apr 25
2022
|
William R Frist Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+12.58%
|
-
|
Apr 25
2022
|
Charles O Holliday Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+4.54%
|
-
|
Apr 25
2022
|
Hugh F Johnston Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+39.75%
|
-
|
Apr 25
2022
|
Michael W Michelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+14.8%
|
-
|
Apr 25
2022
|
Wayne Joseph Riley Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+6.68%
|
-
|
Apr 25
2022
|
Andrea B Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+45.53%
|
-
|